z-logo
open-access-imgOpen Access
The Use of Erdafitinib in Treating Urothelial Carcinoma
Author(s) -
Pippa Wysong
Publication year - 2019
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000586268.14895.20
Subject(s) - medicine , bladder cancer , oncology , tyrosine kinase inhibitor , cancer , carcinoma , cancer research , metastatic urothelial carcinoma , fibroblast growth factor receptor , fibroblast growth factor , urothelial carcinoma , receptor

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom